2.6
2023

Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19 vaccine: not just PEG

Show more: Authors information and Publication history
Authors Information

Unit of Allergy and Clinical Immunology, San Giovanni di Dio Hospital, Azienda USL Toscana Centro, Florence, Italy

History

Published online: 29 April 2021
Accepted: 23 April 2021
Received: 12 March 2021

KEY WORDS
mRNA COVID-19 vaccine; hypersensitivity; allergic reactions; lipid nanoparticles; polyethylene glycols.

Table of Content: Vol. 53 (No. 5) 2021 September

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024